Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neck.

Adenosine-mediated immunosuppression in patients with squamous cell carcinoma of the head and neck. HNO. 2016 Apr 6; Authors: Mandapathil M Abstract This review article describes the potential role of ectonucleotidase activity, adenosine metabolism, and the adenosinergic signaling pathway in the suppression of the host immune system in patients with head and neck cancer. Identifying such mechanisms leads to a better understanding of immunosuppressive mechanisms in this patient population. Further, potential targets for immunotherapy in an adjuvant approach to treating squamous cell carcinoma of the head and neck in the future might be identified and improve the prognosis of these patients. PMID: 27052632 [PubMed - as supplied by publisher]
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research